Should we be in a hurry to abandon anthracyclines due to cardiotoxicity concerns? Think again. Weigh the risk benefits. More to come.
Should we be in a hurry to abandon anthracyclines due to cardiotoxicity concerns? Think again. Weigh the risk benefits. More to come.